D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 8.95% |
| 4 | Communication Services | 6.76% |
| 5 | Financials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Evolent Health
EVH
$475M
| $521K | ﹤0.01% |
32,501
+14,673
| +82% | +$194K |
|
|
ESPR
3252
CALL
DELISTED
Esperion Therapeutics
ESPR
| $520K | ﹤0.01% |
20,000
| – | – |
|
3253
Addus HomeCare
ADUS
$2.14B
| $519K | ﹤0.01% |
4,431
+209
| +5% | +$21.6K |
|
3254
Broadstone Net Lease
BNL
$4.29B
| $519K | ﹤0.01% |
+26,522
| New | +$469K |
|
3255
Sensient Technologies
SXT
$5.4B
| $519K | ﹤0.01% |
7,040
-6,001
| -46% | -$419K |
|
3256
Hormel Foods
HRL
$13.9B
| $518K | ﹤0.01% |
11,123
-453,967
| -98% | -$22.1M |
|
3257
Eagle Bancorp
EGBN
$867M
| $517K | ﹤0.01% |
12,507
-4,668
| -27% | -$164K |
|
3258
National CineMedia
NCMI
$354M
| $517K | ﹤0.01% |
13,907
-3,935
| -22% | -$120K |
|
3259
PUT
Ovintiv
OVV
$17.5B
| $517K | ﹤0.01% |
36,000
| – | – |
|
3260
Cavco Industries
CVCO
$4.39B
| $516K | ﹤0.01% |
+2,942
| New | +$546K |
|
3261
Sony
SONY
$123B
| $516K | ﹤0.01% |
25,510
-36,740
| -59% | -$639K |
|
|
SPWR
3262
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $513K | ﹤0.01% |
+20,000
| New | +$404K |
|
3263
Goosehead Insurance
GSHD
$1.39B
| $512K | ﹤0.01% |
+4,102
| New | +$469K |
|
3264
PUT
Allstate
ALL
$66.9B
| $506K | ﹤0.01% |
4,600
+1,300
| +39% | +$128K |
|
3265
MGP Ingredients
MGPI
$378M
| $506K | ﹤0.01% |
+10,744
| New | +$463K |
|
3266
CALL
Hilton Grand Vacations
HGV
$3.84B
| $505K | ﹤0.01% |
16,100
| – | – |
|
3267
PUT
Travelers Companies
TRV
$80.8B
| $505K | ﹤0.01% |
3,600
+500
| +16% | +$64.2K |
|
3268
PUT
Ionis Pharmaceuticals
IONS
$9.35B
| $503K | ﹤0.01% |
8,900
| – | – |
|
3269
Carter Bankshares
CARE
$756M
| $502K | ﹤0.01% |
46,845
+17,787
| +61% | +$151K |
|
|
APHA
3270
DELISTED
Aphria Inc. Common Shares
APHA
| $502K | ﹤0.01% |
72,566
+57,666
| +387% | +$360K |
|
3271
Actinium Pharmaceuticals
ATNM
$27M
| $501K | ﹤0.01% |
+64,181
| New | +$697K |
|
3272
Luxfer Holdings
LXFR
$460M
| $499K | ﹤0.01% |
30,395
-7,643
| -20% | -$112K |
|
3273
OSI Systems
OSIS
$3.57B
| $499K | ﹤0.01% |
5,353
-7,774
| -59% | -$665K |
|
3274
Domino's
DPZ
$11B
| $498K | ﹤0.01% |
1,300
-29,005
| -96% | -$11.4M |
|
|
SOHU
3275
Sohu.com
SOHU
$336M
| $498K | ﹤0.01% |
31,214
+15,573
| +100% | +$286K |
|
Similar funds
D.E. Shaw & Co's Q4 2020 Portfolio in Review
As of Q4 2020, D.E. Shaw & Co held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Snowflake worth $147M.
- D.E. Shaw & Co's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- D.E. Shaw & Co added most to Snap in Q4 2020, an estimated $362M increase.
- D.E. Shaw & Co's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- D.E. Shaw & Co fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- D.E. Shaw & Co opened 563 new positions and closed 477 in Q4 2020.
- D.E. Shaw & Co's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.